Literature DB >> 29288268

Identification and Characterization of Circular RNAs as a New Class of Putative Biomarkers in Diabetes Retinopathy.

Shu-Jie Zhang1, Xue Chen2, Chao-Peng Li3, Xiu-Miao Li4, Chang Liu1,4, Bai-Hui Liu5, Kun Shan1, Qin Jiang4, Chen Zhao1,6,7, Biao Yan1,6,7.   

Abstract

Purpose: To reveal the expression profile and clinical significance of circular RNAs (circRNAs) in diabetic retinopathy (DR).
Methods: Circular RNA microarrays were performed to identify DR-related circRNAs. Gene ontology (GO) enrichment and KEGG analysis was performed to determine the biologic modules and signaling pathway. TargetScan and miRana program was used to predict circRNA/miRNA interaction. Quantitative PCR assays were performed to detect circRNA expression pattern in clinical samples. Ki67 staining, Transwell, tube formation, and spheroid sprouting assays were performed to investigate the role and mechanism of circRNA in endothelial angiogenic function.
Results: A total of 529 circRNAs were aberrantly expressed in diabetic retinas. The host genes of differentially expressed circRNAs were targeted to ATP binding (biologic process); extracellular exosome (cellular component); and intracellular signal transduction (molecular function). Circ_0005015 was verified to be upregulated in the plasma, vitreous sample, and fibrovascular membranes of DR patients. Circ_0005015 facilitated retinal endothelial angiogenic function via regulating endothelial cell proliferation, migration, and tube formation. Circ_0005015 acted as miR-519d-3p sponge to inhibit miR-519d-3p activity, leading to increased MMP-2, XIAP, and STAT3 expression. Conclusions: circRNAs are involved in DR pathogenesis, and thus serve as potential biomarkers of DR diagnosis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29288268     DOI: 10.1167/iovs.17-22698

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  48 in total

1.  Inhibition of hsa_circ_0002570 suppresses high-glucose-induced angiogenesis and inflammation in retinal microvascular endothelial cells through miR-1243/angiomotin axis.

Authors:  Guodan Liu; Shifeng Zhou; Xinge Li; Xuchen Ding; Miao Tian
Journal:  Cell Stress Chaperones       Date:  2020-04-21       Impact factor: 3.667

2.  Circular RNAs in human and vertebrate neural retinas.

Authors:  Lan-Fang Sun; Bing Zhang; Xue-Jiao Chen; Xiao-Yun Wang; Bo-Wen Zhang; Yang-Yang Ji; Kun-Chao Wu; Jinyu Wu; Zi-Bing Jin
Journal:  RNA Biol       Date:  2019-04-02       Impact factor: 4.652

Review 3.  Interplay between circular RNA, microRNA, and human diseases.

Authors:  Bimaljeet Kour; Suruchi Gupta; Ravail Singh; Yengkhom Sophiarani; Prosenjit Paul
Journal:  Mol Genet Genomics       Date:  2022-01-27       Impact factor: 3.291

4.  lncRNA HOTAIR Protects Myocardial Infarction Rat by Sponging miR-519d-3p.

Authors:  Dongying Zhang; Bingjian Wang; Min Ma; Kun Yu; Qing Zhang; Xiwen Zhang
Journal:  J Cardiovasc Transl Res       Date:  2019-01-03       Impact factor: 4.132

Review 5.  Circular RNAs and hereditary bone diseases.

Authors:  Naixiang Zhai; Yanqin Lu; Yanzhou Wang; Xiuzhi Ren; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2018-02

Review 6.  The Function and Therapeutic Potential of Circular RNA in Cardiovascular Diseases.

Authors:  Kai Wang; Xiang-Qian Gao; Tao Wang; Lu-Yu Zhou
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-16       Impact factor: 3.727

Review 7.  Circular RNAs open a new chapter in cardiovascular biology.

Authors:  Simona Aufiero; Yolan J Reckman; Yigal M Pinto; Esther E Creemers
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

Review 8.  Circular RNAs in β-cell function and type 2 diabetes-related complications: a potential diagnostic and therapeutic approach.

Authors:  Hassan Ghasemi; Zolfaghar Sabati; Hamid Ghaedi; Zaker Salehi; Behnam Alipoor
Journal:  Mol Biol Rep       Date:  2019-07-13       Impact factor: 2.316

Review 9.  Circular RNAs: Novel target of diabetic retinopathy.

Authors:  Huan-Ran Zhou; Hong-Yu Kuang
Journal:  Rev Endocr Metab Disord       Date:  2021-03-24       Impact factor: 6.514

10.  Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis.

Authors:  Meng Zhang; Yi Liu; Jing Chen; Lei Chen; Li Zhang; Xianguo Chen; Zongyao Hao; Chaozhao Liang
Journal:  J Inflamm Res       Date:  2022-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.